Archive: 11/01/2018

Why a drug treatment for dementia eludes researchers

Finding a cure for neurodegenerative diseases such as Alzheimer's is challenging. They're difficult to diagnose, and drugs struggle to get into the brain as the brain's blood supply is largely separate to the rest of the ...

Jan 11, 2018

0

19

How the immune system curbs its own mistakes

When we encounter a pathogen, the immune system is usually able to respond quickly and forcefully to protect us from infection. Some of its preparedness is inherent in the process by which white blood cells called B cells ...

Jan 11, 2018

Scientists use gene expression to understand how astrocytes change with age

Potentially explaining why even healthy brains don't function well with age, Salk researchers have discovered that genes that are switched on early in brain development to sever connections between neurons as the brain fine-tunes, ...

Jan 11, 2018

0

127

What are antioxidants? And are they truly good for us?

Antioxidants seem to be everywhere; in superfoods and skincare, even chocolate and red wine. Products that contain antioxidants are marketed as essential for good health, with promises to fight disease and reverse ageing.

Jan 11, 2018

0

4

Philippines says deaths in vaccine row 'consistent with' dengue

The Philippines said Thursday that some of the 14 children who died after receiving a controversial vaccine showed signs of "severe dengue", as investigators probe the drug whose use was suspended due to health concerns.

Jan 11, 2018

0

1

Objectification of women results in lack of empathy

Sexualized representations, especially the emphasis of secondary sexual characteristics, can change the way we perceive an individual. An international team of researchers led by Giorgia Silani from the Faculty of Psychology ...

Jan 11, 2018

1

97

Guidelines for management of recurrent pituitary tumours recommend new drug as first line treatment

New guidelines for managing recurrent pituitary tumours identify the drug temozolomide, as first line chemotherapy treatment. The guidelines, published in the European Journal of Endocrinology and produced by the European ...

Jan 11, 2018

Researchers identify new melatonin-based molecular targets that will allow to design new drugs against Parkinson's

A team of scientists led by Darío Acuña-Castroviejo, professor at the University of Granada (UGR), has published the results of a new breakthrough in molecular mechanisms of the anti-Parkinsonian activity of melatonin.

Jan 11, 2018